For subscribers
Singapore biomed production breaks out of slump, EDB says at least 1,000 new jobs in pipeline
Sign up now: Get ST's newsletters delivered to your inbox
Industry players said the inherently volatile industry remains robust, with firms actively pursuing growth opportunities here.
PHOTO: ST FILE
Follow topic:
SINGAPORE - Singapore’s biomedical sector roared back to life in September, after a six-month manufacturing slump.
Data from the Economic Development Board (EDB) on Oct 25 showed that output of the sector, which includes the biopharmaceutical and medical technology segments, grew 62 per cent year on year in September.
